Photopheresis in solid organ transplant rejection.

abstract：BACKGROUND:Plasma exchange (PE) and double filtration plasmapheresis (DFPP) are known as effective treatment options for hyperviscosity syndrome (HVS) caused by Waldenstrom macroglobulinemia. Nonetheless, few data are available for the relation between the prescribed dose of apheresis and the reduction rate of target m...

journal_title：Journal of clinical apheresis

authors： Miyamoto Y,Hamasaki Y,Matsumoto A,Doi K,Noiri E,Nangaku M

更新日期：2018-10-01 00:00:00

abstract：:The supply of deceased donor kidneys is inadequate to meet demand. To expand the pool of potential donors, ABO-incompatible transplants from living donors have been performed. We present the Mayo Clinic experience with such transplants. Enrollment was open to patients when the only available potential living kidney do...

journal_title：Journal of clinical apheresis

authors： Winters JL,Gloor JM,Pineda AA,Stegall MD,Moore SB

更新日期：2004-01-01 00:00:00

abstract：:Blood group incompatibility remains a significant barrier to kidney transplantation. Approximately, one-third of donors are blood group incompatible with their intended recipient. Options for these donor-recipient pairs include blood group incompatible transplantation or kidney paired donation. However, the optimal pr...

journal_title：Journal of clinical apheresis

authors： Yabu JM,Fontaine MJ

更新日期：2015-12-01 00:00:00

abstract：:The blood flow property is one of the factors determining blood perfusion and oxygen supply. The viscosity of the blood is primarily related to the hematocrit, but also to the amount of fibrinogen and other macromolecules present in the blood. Patients with ischemic heart disease have shown a rapid and safe improvemen...

journal_title：Journal of clinical apheresis

authors： Fadul JE,Linde T,Sandhagen B,Wikström B,Danielson BG

更新日期：1997-01-01 00:00:00

abstract：:This is an attempt at comparing two cell separators for plateletpheresis, namely the Fresenius AS.TEC 204 and Haemonetics MCS 3p, at a tertiary care center in India. Donors who weighed between 55-75 kg, who had a hematocrit of 41-43%, and platelet counts of 250x10(3)-400x10(3)/microl were selected for the study. The c...

journal_title：Journal of clinical apheresis

authors： Ranganathan S

更新日期：2007-02-01 00:00:00

abstract：:The cell separator MCS-3P is an apheresis system offering the flexibility to collect standardized red blood cells, plasma, and/or platelets from one donor. Two different programs were used for the red cell apheresis--RBCP (collection of one unit of red cells and two units of plasma) and RBCPS (one unit of red cells an...

journal_title：Journal of clinical apheresis

authors： Matthes G,Tofote U,Krause KP,Pawlow I,Kucera W,Lerche D

更新日期：1994-01-01 00:00:00

abstract：:Folinic acid (FA) has been reported to expand the pool of peripheral blood stem cells (PBSC) after chemotherapy. We evaluated the efficacy of FA for harvesting PBSC following cytotoxic chemotherapy in 4 patients with acute leukemia. After achieving a complete remission (CR), 3 courses of chemotherapy for a consolidati...

journal_title：Journal of clinical apheresis

authors： Teshima T,Harada M,Takamatsu Y,Inaba S,Kondo S,Akashi K,Okamura T,Niho Y

更新日期：1992-01-01 00:00:00

abstract：:During the course of heparin-induced extracorporeal lipoprotein apheresis, a patient with no prior known renal impairment or proteinuria demonstrated sustained improvement in estimated glomerular filtration rate, commensurate with reduction in serum lipids and creatine phosphokinase levels. Causes and implications of ...

journal_title：Journal of clinical apheresis

authors： Chandran PK

更新日期：2011-01-01 00:00:00

abstract：:One of the most serious problems in applying leukapheresis to human infants is the large extracorporeal blood volume (ECV), resulting in substantial loss of platelets and red blood cells (RBCs). In this study, we developed a safe and effective modified procedure to collect peripheral blood stem cells (PBSCs) from rhes...

journal_title：Journal of clinical apheresis

authors： Ageyama N,Kimikawa M,Eguchi K,Ono F,Shibata H,Yoshikawa Y,Terao K

更新日期：2003-01-01 00:00:00

abstract：:Either bone marrow or peripheral blood may be harvested to provide hematopoietic stem cells (HSC) for autologous transplantation. Both, however, comprise heterogeneous cell populations. The HSC necessary for successful engraftment constitute a very small fraction of the cells harvested. After collection, the harvested...

journal_title：Journal of clinical apheresis

authors： Rowley SD

更新日期：1992-01-01 00:00:00

abstract：:This study examined the incidence and predictors of peripheral blood stem cell (PBSC) mobilization failure in patients with multiple myeloma (MM). Retrospective data for 104 patients who received granulocyte colony-stimulating factor (G-CSF) alone or with cyclophosphamide as mobilization regimens were analyzed. The ra...

journal_title：Journal of clinical apheresis

authors： Jung SH,Yang DH,Ahn JS,Kim YK,Kim HJ,Lee JJ

更新日期：2014-12-01 00:00:00

abstract：:Idiopathic inflammatory demyelinating diseases (IIDDs) of the central nervous system, of which multiple sclerosis is the prototype, represent a family of monophasic, recurrent or progressive diseases with overlapping clinical and pathological manifestations. While most patients recover spontaneously or following a bri...

journal_title：Journal of clinical apheresis

authors： Weinshenker BG

更新日期：1999-01-01 00:00:00

abstract：:Many apheresis units lack the resources to acquire customized computer software for record keeping. We have adapted a commercially available "spreadsheet" program (Lotus 1-2-3) to aid in quality control activities for plateletpheresis. Data are entered in a grid pattern wherein each donation occupies one row and succe...

journal_title：Journal of clinical apheresis

authors： McLeod BC,Viernes A,Reed S,Sassetti RJ

更新日期：1990-01-01 00:00:00

abstract：:The removal of specific antibody in experimental animals has been reported to result in a subsequent increase in antibody to levels equal to (rebound) or exceeding those existing prior to removal (overshoot). Anecdotal reports suggest that rebound antibody synthesis after plasmapheresis may occur in humans with autoim...

journal_title：Journal of clinical apheresis

authors： Nasca TJ,Muder RR,Thomas DB,Schrecker JC,Ruben FL

更新日期：1990-01-01 00:00:00

abstract：BACKGROUND:Hyperleukocytosis is commonly seen in acute and chronic leukemias. Therapeutic leukocytapheresis using an automatic cell separator can help to achieve prompt leukoreduction to reduce the rate of thrombotic events and early mortality as well as to prevent tumor lysis syndrome. AIM:In this study, we report a ...

journal_title：Journal of clinical apheresis

authors： Nguyen TH,Bach KQ,Vu HQ,Nguyen NQ,Duong TD,De Reys S,Wheeler J

更新日期：2020-04-01 00:00:00

abstract：:Mobilization regimens for CD34+ cells have generally been judged successful based on the number of cells collected without evaluating mobilization separately from collection. Using retrospective data for patients who collected CD34+ cells on Total Therapy protocols 3a/3b (VTD-PACE) and Total Therapy 4/5 using a novel ...

journal_title：Journal of clinical apheresis

authors： Abuabdou A,Rosenbaum ER,Usmani SZ,Barlogie B,Cottler-Fox M

更新日期：2014-10-01 00:00:00

abstract：BACKGROUND:In organ transplantation, apheresis is frequently used for removal of anti-HLA antibodies. However, it is unclear whether plasmapheresis (PP) or semi-selective immunoadsorption (IA) should be employed, and the optimal number of apheresis sessions required to reach post-treatment objectives is also unknown. ...

journal_title：Journal of clinical apheresis

authors： Jambon F,Merville P,Guidicelli G,Taton B,De Précigout V,Couzi L,Moreau K,Visentin J

更新日期：2020-11-30 00:00:00

abstract：:Heparin-induced thrombocytopenia (HIT) can occur following exposure to heparin and is characterized by thrombocytopenia with increased risk for thrombosis. This condition is mediated by formation of immunoglobulin G antibodies against platelet factor 4/heparin complexes that can subsequently lead to platelet activatio...

journal_title：Journal of clinical apheresis

authors： Raval JS,Park YA,Perjar I,Mazepa MA,Vincent BG,Ma AD,Rollins-Raval MA

更新日期：2020-01-01 00:00:00

abstract：:Extracorporeal photopheresis (ECP) has been shown to be clinically effective in the treatment of many T cell-mediated conditions. ECP's mechanism of action includes the induction of apoptosis and the release of pro-inflammatory cytokines. Recently, we have observed early lymphoid apoptosis, detectable immediately post...

journal_title：Journal of clinical apheresis

authors： Bladon J,Taylor P

更新日期：2002-01-01 00:00:00

abstract：OBJECTIVE:Effects of therapeutic plasma exchange (TPE) on immune cells and their cytokine production in MS, are unknown. Since interleukine-6 and tumor growth factor-β have critical roles in MS immunopathogenesis, the impacts of TPE on the expression of these cytokines and their receptors on the surface of CD4+ T lymph...

journal_title：Journal of clinical apheresis

authors： Jamshidian A,Abd-Nikfarjam B,Khademi Z,Shaygannejad V,Salehi M

更新日期：2020-04-01 00:00:00

abstract：BACKGROUND:Nephrogenic systemic fibrosis (NSF), also known as nephrogenic sclerosing dermopathy (NSD), is a rare progressive fibrosing disease associated with gadolinium based dyes in patients with renal disease. The exact pathophysiology is not well understood. Accepted treatments include corticosteroids, immune modul...

journal_title：Journal of clinical apheresis

authors： Poisson JL,Low A,Park YA

更新日期：2013-08-01 00:00:00

abstract：:For therapeutic plasma exchange (TPE), continuous flow separators are known to be efficient as exemplified by Fresenius AS104 and COBE Spectra. The AS104 uses an interface monitoring system in the centrifuge during TPE, whereas Spectra uses computer algorithms to establish the plasma-cell interface. To determine the p...

journal_title：Journal of clinical apheresis

authors： Burgstaler EA,Pineda AA

更新日期：2001-01-01 00:00:00

abstract：:Sickle cell disease (SCD) patients are prone to develop complications that include stroke, acute chest syndrome, and other crises. Some of these complications require chronic transfusion therapy or red cell exchange (RCE), either for therapeutic or prophylactic reasons. Due to a discrepancy of red cell antigens betwee...

journal_title：Journal of clinical apheresis

authors： Sarode R,Altuntas F

更新日期：2006-12-01 00:00:00

abstract：:In the United States, therapeutic plasma exchange (TPE) is both performed and requested by a wide range of services, often on an empiric basis (before a diagnosis is established). Whether empiric therapy is beneficial has not been established. Patients were identified from an electronic procedure log that included tho...

journal_title：Journal of clinical apheresis

authors： Yeo FE,Bohen EM,Yuan CM,Sawyers ES,Abbott KC

更新日期：2005-12-01 00:00:00

abstract：:Mobilized PBSC are the main source for allogeneic HSCT. We aimed to evaluate factors that affect CD34+ cell yield including the donor's age, gender, BSA, processed blood volume and the method of G-CSF dose calculation. Data from 170 healthy donors were analyzed. The concentration of CD34+ cells in the peripheral blood...

journal_title：Journal of clinical apheresis

authors： Machaczka M,Hägglund H,Staver E,Joks M,Hassan M,Wahlin BE,Axdorph Nygell U

更新日期：2017-12-01 00:00:00

abstract：:Modern techniques of mechanical hemapheresis have made it possible to selectively remove vast quantities of lymphocytes and plasma immunoglobulins, and the concentration of these substances in donor blood can fall below the normal range. It is feared that this may lead to immunosuppression; a condition associated in s...

journal_title：Journal of clinical apheresis

authors： Strauss RG

更新日期：1984-01-01 00:00:00

abstract：:Management of aTTP in patients who refuse or are intolerant to plasma remains challenging, but new drugs can be implemented with success. A 39-year-old woman presented to the Emergency department for bruises at the upper and lower limbs together with worsening anemia and thrombocytopenia; PLASMIC score was seven, indi...

journal_title：Journal of clinical apheresis

authors： Perrone S,Passucci M,Ortu La Barbera E,Capriata M,Ferretti A,Mecozzi A,Giovangrossi P,Equitani F,Cimino G

更新日期：2021-01-18 00:00:00

abstract：:The literature on the use of therapeutic apheresis is often criticized for the preponderance of low to very low quality evidence. Shehata et al. examined the apheresis literature published between 1976 and 1999 and found a lack of randomized controlled trials with those identified demonstrating significant limitations...

journal_title：Journal of clinical apheresis

authors： Winters JL

更新日期：2013-02-01 00:00:00

abstract：BACKGROUND:Autologous stem cell transplantation (auto-SCT) is a treatment approach in non-Hodgkin lymphoma (NHL) patients. The options for mobilization of CD34+ cells to support high-dose therapy are granulocyte-colony stimulating factors (G-CSFs) alone or after chemotherapy. Limited data exist on the efficacy of lipeg...

journal_title：Journal of clinical apheresis

authors： Partanen A,Turunen A,Valtola J,Vasala K,Ågren L,Penttilä K,Pyörälä M,Kuittinen T,Mäntymaa P,Pelkonen J,Jantunen E,Varmavuo V

更新日期：2020-08-01 00:00:00

abstract：:Blood component donations by apheresis have become more common in modern blood transfusion practices. We compared three apheresis instruments (Fenwal Amicus, Fresenius COM.TEC, and Trima Accel) with regard to platelet (PLT) yield, collection efficiency (CE), and collection rate (CR). The single-needle or double-needle...

journal_title：Journal of clinical apheresis

authors： Keklik M,Eser B,Kaynar L,Sivgin S,Keklik E,Solmaz M,Ozturk A,Buyukoglan R,Yay M,Cetin M,Unal A

更新日期：2015-06-01 00:00:00